Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial
Yishen Wu, Jingjun Huang, Licong Liang, Wenbo Shi et al.
Citations
3 citations
Journal
BMC Cancer
Topics
Hepatocellular Carcinoma Treatment and Prognosis
Field-Weighted Citation Impact (FWCI)
3.97
article
Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial
Yishen Wu, Jingjun Huang, Licong Liang, Wenbo Shi, Xiaoyang Hong, Kangshun Zhu, Wensou Huang, Yongjian Guo, Mingyue Cai, Jingwen Zhou, Ye Chen, Liteng Lin, J. D. Huang
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
BMC CancerVol. 25(1)
Institutions
Shantou University (CN), Second Affiliated Hospital of Guangzhou Medical University (CN), Yue Bei People's Hospital (CN), Shanghai Sixth People's Hospital (CN), Guangzhou Medical University (CN)
Funders
Guangzhou Medical University, National Natural Science Foundation of China, Southern Medical University